Dolby Laboratories, Inc. DLB Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 88.1%-0.8pp | 89%+0.7pp | 88.3%-0.5pp | 88.7%-1.1pp | |
| Operating margin | 19.6%-0.6pp | 20.3%+3.4pp | 16.9%+0.4pp | 16.5%-10.4pp | |
| Net margin | 18.9%-1.7pp | 20.6%+5.1pp | 15.4%+0.8pp | 14.7%-9.5pp | |
| Returns | |||||
| Return on equity | 10%-0.8pp | 10.8%+2.1pp | 8.7%+1.1pp | 7.6%-4.7pp | |
| Return on invested capital | 13.9%+1.3pp | 12.6%+2.1pp | 10.5%-0.8pp | 11.3%-10.1pp | |
| Efficiency | |||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.5×0.0× | 0.4×0.0× | |
| Liquidity | |||||
| Current ratio | 3.2×+0.3× | 2.9×-0.7× | 3.5×-1.2× | 4.7×-0.9× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -2.1×-0.5× | -1.6×+0.7× | -2.3×-0.4× | -1.9×+0.7× | |
| Per Share | |||||
| Book value per share | $26.90+5.7% | $25.45+5.6% | $24.10+9.4% | $22.03-11.3% | |
| Valuation | |||||
| Market capitalization | $6.94B-4.9% | $7.3B-3.7% | $7.58B+19.1% | $6.36B-28.5% | |
| Price / earnings | 27.2×-0.7× | 27.9×-9.9× | 37.8×+3.2× | 34.6×+5.9× | |
| Price / sales | 5.1×-0.6× | 5.7×-0.1× | 5.8×+0.8× | 5.1×-1.9× | |
| Price / book | 2.6×-0.3× | 2.9×-0.3× | 3.2×+0.4× | 2.8×-0.6× | |
| EV / EBITDA | 17.5×-2.7× | 20.3×-2.6× | 22.8×+3.2× | 19.6×+2.1× | |
| Dividend yield | 1.8%+0.3pp | 1.6%+0.2pp | 1.4%-0.2pp | 1.6%+0.6pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Dolby Laboratories, Inc.'s profit margins?
- Dolby Laboratories, Inc. (DLB) runs a 87.4% gross margin and a 18.5% operating margin, with a 17.9% net margin.
- Where do Dolby Laboratories, Inc.'s ratios come from?
- Every ratio is computed from Dolby Laboratories, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
